The Blend, Episode 3: Integrative Approaches to Treating HS, Part 2
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
The Blend, Episode 3: Integrative Approaches to Treating HS, Part 2
-
Narrado por:
-
De:
The hosts review the pros and cons of available medical and surgical treatments for hidradenitis suppurativa (HS), a chronic inflammatory skin condition that causes painful bumps and lesions, often in areas such as the armpits and groin. They also offer a peek into the HS pipeline. Spoiler alert: It’s booming. Key Takeaways:
- Doxycycline and other systemic antibiotics can still play a role in treating HS.
- Hormonal and metabolic modulators, including spironolactone, metformin, and finasteride, can be safe and efficacious for HS.
- There are now three biologics approved for treating HS: adalimumab, secukinumab (Cosentyx, Novartis), and bimekizumab (Bimzelx, UCB).
- Surgical excision of the affected site is often a viable option.
- Janus kinase (JAK) inhibitors are being studied in HS. Stay tuned.
Todavía no hay opiniones